As consumers kick off the new year focused on wellness, interest in hair restoration solutions peaks. A January 2026 Consumer Report examines PeterMD and similar telehealth platforms, highlighting how prescription hair loss treatments are increasingly accessed online under licensed medical supervision.
The report explores consumer search trends for “best peptides for hair growth” and related queries, contextualizing the growing popularity of both FDA-approved medications and compounded formulations for hair restoration. It emphasizes that hair loss treatment decisions should be guided by licensed healthcare providers, and that this report is for informational purposes only.
Seasonal Surge in Hair Loss Treatment Searches
Consumer interest in hair restoration rises in early January, coinciding with seasonal wellness behavior often framed as “new year, new you.” Searches frequently include terms like “minoxidil vs finasteride,” “telehealth hair loss,” and “hair loss treatments 2026,” reflecting comparisons across treatment types rather than a single solution.
The report notes that consumers evaluate treatments based on several factors: delivery format preference (topical vs oral), level of medical supervision, convenience, and understanding of the supporting clinical evidence. Preferences often influence satisfaction more than ingredient selection alone.
Primary Hair Loss Treatment Categories
1. FDA-Approved Medications
- Minoxidil (topical): Stimulates blood flow to hair follicles and supports regrowth. Over-the-counter options vary in concentration.
- Finasteride (oral): Reduces DHT levels to protect hair follicles from male pattern baldness. Prescription-only and not approved for use by women or pregnant individuals.
2. Compounded Prescription Formulations
Custom combinations, often including FDA-approved ingredients like minoxidil and finasteride, are prepared by licensed compounding pharmacies. PeterMD offers FollicureRX, a compounded topical spray combining minoxidil, finasteride, and ketoconazole. These products are not FDA-approved as finished medications.
3. Research Peptides and Emerging Treatments
Includes compounds like GHK-Cu and other growth factor peptides. Still in early-stage research, these are not FDA-approved for hair loss treatment.
FDA Guidance and Safety Considerations
In April 2025, the FDA issued a safety communication regarding compounded topical finasteride products, noting potential adverse effects including sexual dysfunction, mood changes, and cognitive impacts. Consumers are advised to consult healthcare providers before starting compounded treatments, including PeterMD’s FollicureRX.
How PeterMD Facilitates Telehealth Hair Loss Treatments
PeterMD operates through a three-entity telehealth model:
- Platform: Connects patients with licensed medical providers.
- Licensed Clinicians: Review patient information and determine prescription appropriateness.
- Partner Pharmacies: Fulfill prescriptions and ship medications directly to patients.
Available treatments include:
- Oral finasteride (1 mg tablets)
- Topical minoxidil
- Finasteride + minoxidil bundle
- FollicureRX compounded topical spray
The platform emphasizes convenience, transparent pricing, and physician-directed care. However, availability is restricted in certain states (e.g., Alabama, Idaho).
Who May Benefit From Telehealth Hair Loss Treatments
- Men with androgenetic alopecia seeking FDA-approved medications or combination approaches
- Individuals prioritizing telehealth convenience over in-person visits
- Consumers interested in compounded formulations addressing multiple hair loss mechanisms
In-person consultations, female-specific treatments, or certain medical conditions may necessitate alternative options.
Treatment Timelines and Expectations
- Weeks 1–4: Early reduction in hair shedding and stimulation of dormant follicles may begin.
- Months 1–3: Hair may feel stronger, with fine new hairs emerging.
- Months 3–6: Visible results may appear with consistent use of finasteride and minoxidil.
- 12+ Months: Full results require long-term adherence; discontinuing treatment typically reverses gains.
Individual outcomes vary, and results are not guaranteed.
Conclusion
January 2026 searches for “best peptides for hair growth” highlight the evolving landscape of hair loss treatments, encompassing FDA-approved medications, compounded formulations, and emerging research options. PeterMD represents one telehealth-driven approach, offering prescription access to both FDA-approved and compounded treatments for men with androgenetic alopecia.
Consumers are advised to consult licensed healthcare providers to ensure treatments align with their medical needs, lifestyle, and preferences. Individual verification of current product offerings, pricing, and availability is essential before making decisions.
